As of Nov 30
| +0.19 / +2.68%|
The 4 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 15.88, with a high estimate of 25.00 and a low estimate of 11.50. The median estimate represents a +118.36% increase from the last price of 7.27.
The current consensus among 4 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.